Jim Simons Palisade Bio, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.11 - $0.52 $52,562 - $248,476	477,840 Added 1395.97%	512,070 $51,000
Q2 2022 Aug 12, 2022	BUY	$0.41 - $1.04 $5,301 - $13,447	12,930 Added 60.7%	34,230 $14,000
Q1 2022 May 13, 2022	SELL	$0.81 - $1.51 $48,466 - $90,350	-59,835 Reduced 73.75%	21,300 $23,000
Q4 2021 Feb 11, 2022	BUY	$1.3 - $2.96 $105,475 - $240,159	81,135 New	81,135 $105,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.93 $341,455 - $571,029	-145,300 Closed	0 $0

Q2 2021 Aug 13, 2021	BUY	$3.49 - $11.34 $507,097 - $1.65 Million	145,300 New	145,300 $591,000

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $323M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.